Details for New Drug Application (NDA): 060516
✉ Email this page to a colleague
The generic ingredient in KANTREX is kanamycin sulfate. There are five drug master file entries for this compound. Additional details are available on the kanamycin sulfate profile page.
Summary for 060516
Tradename: | KANTREX |
Applicant: | Apothecon |
Ingredient: | kanamycin sulfate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 060516
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 500MG BASE | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription